Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

por Boers, Maarten, Hartman, Linda, Opris-Belinski, Daniela, Bos, Reinhard, Kok, Marc R, Da Silva, Jose AP, Griep, Eduard N, Klaasen, Ruth, Allaart, Cornelia F, Baudoin, Paul, Raterman, Hennie G, Szekanecz, Zoltan, Buttgereit, Frank, Masaryk, Pavol, Klausch, L Thomas, Paolino, Sabrina, Schilder, Annemarie M, Lems, Willem F, Cutolo, Maurizio
Publicado 2022

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

por Ghiti Moghadam, Marjan, Lamers-Karnebeek, Femke B. G., Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, van Schaeybroeck, Barbara, Klaasen, Ruth, van Onna, Marieke, Bernelot Moens, Hein J., Visser, Henk, Schilder, Annemarie M., Kok, Marc R., Landewé, Robert B. M., van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.
Publicado 2019

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

por Ghiti Moghadam, Marjan, Lamers-Karnebeek, Femke B. G., Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, Schilder, Annemarie M., Visser, Henk, Sasso, Eric H., Chernoff, David, Lems, Willem F., van Schaardenburg, Dirk-Jan, Landewe, Robert, Bernelot Moens, Hein J., Radstake, Timothy R. D. J., van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.
Publicado 2018